Latest Biotech Startup Funding Rounds
Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.
- Rounds
- 46 Sep 26 – Oct 25, 2026
- Disclosed funding
- $1.9B 29 disclosed amounts
- Median round
- $25M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
 AnaCardioCompany profile AnaCardio develops oral medicines intended to improve heart muscle contraction in people with heart failure. AnaCardio develops oral medicines intended to improve heart muscle contraction in people with heart failure. | €62.5M | Series B | Biotech | Sweden | Investors | |
| AT Aptadir TherapeuticsCompany profile RNA therapeutics designed to restore expression of silenced genes RNA therapeutics designed to restore expression of silenced genes | €40M | Seed | Biotech | Italy | Investors | |
| a ai3BioCompany profile ai3Bio develops therapies designed to remove disease-causing Th17 immune cells, using antibody and lipid-nanoparticle platforms to address autoimmune disease. ai3Bio develops therapies designed to remove disease-causing Th17 immune cells, using antibody and lipid-nanoparticle platforms to address autoimmune disease. | $48M | Series A | Biotech | United States | Investors | |
| BT Breye Therapeutics develops oral medicines for retinal diseases. | €67.5M | Series A | Biotech | Denmark | Investors | |
| MB MOYOM BiotechCompany profile Develops absorbable biomaterials and implantable medical devices for regenerative aesthetic treatments. Develops absorbable biomaterials and implantable medical devices for regenerative aesthetic treatments. | Undisclosed | Financing roundUndisclosed | Biotech, Healthtech | China | Investors | |
| W WonderTxCompany profile AI models designed to discover oral medicines for diseases currently treated with injectable drugs. AI models designed to discover oral medicines for diseases currently treated with injectable drugs. | $125K | Seed | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Sep 26, 2026
- 1Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
3rounds1led - 2Lux Capital
Warp Sciences, Warhound, Coherence Neuro
3rounds0led - 34BIO Capital
Estuary Biotherapeutics, Undecimal Bio, Aptadir Therapeutics
3rounds2led - 4Novo Holdings
OMass Therapeutics, AnaCardio, Breye Therapeutics
3rounds3led - 5Y Combinator (YC)
Molagri, Sensible Biotechnologies, WonderTx
3rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.